CELLINI, Luigina
 Distribuzione geografica
Continente #
NA - Nord America 8.487
EU - Europa 7.260
AS - Asia 6.063
SA - Sud America 785
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 8
Totale 22.691
Nazione #
US - Stati Uniti d'America 8.346
SG - Singapore 2.262
CN - Cina 1.972
IT - Italia 1.647
UA - Ucraina 1.133
IE - Irlanda 996
TR - Turchia 853
SE - Svezia 804
FR - Francia 672
BR - Brasile 655
GB - Regno Unito 647
DE - Germania 506
IN - India 450
FI - Finlandia 258
VN - Vietnam 258
RU - Federazione Russa 177
PL - Polonia 165
CA - Canada 82
AR - Argentina 56
CZ - Repubblica Ceca 51
MX - Messico 43
NL - Olanda 43
HK - Hong Kong 42
IR - Iran 37
BD - Bangladesh 32
JP - Giappone 31
RO - Romania 28
BE - Belgio 27
KR - Corea 26
IQ - Iraq 23
EC - Ecuador 22
ZA - Sudafrica 22
ES - Italia 19
LT - Lituania 17
CO - Colombia 15
EU - Europa 15
ID - Indonesia 15
AT - Austria 13
CH - Svizzera 13
GR - Grecia 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
AU - Australia 8
CL - Cile 7
IL - Israele 7
PH - Filippine 7
TN - Tunisia 7
DZ - Algeria 6
EG - Egitto 6
SA - Arabia Saudita 6
EE - Estonia 5
KE - Kenya 5
MA - Marocco 5
PT - Portogallo 5
AL - Albania 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
ET - Etiopia 4
OM - Oman 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
KZ - Kazakistan 3
LY - Libia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PK - Pakistan 3
RS - Serbia 3
SL - Sierra Leone 3
UY - Uruguay 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LU - Lussemburgo 1
MT - Malta 1
SC - Seychelles 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 22.691
Città #
Singapore 1.689
Jacksonville 1.296
Chandler 1.004
Dublin 949
Dallas 495
Princeton 487
Beijing 466
Southend 456
Izmir 443
Nanjing 405
Dearborn 381
Ashburn 351
Chieti 253
Wilmington 245
Los Angeles 222
Santa Clara 222
Cambridge 220
New York 179
The Dalles 179
Ann Arbor 169
Tongling 165
Buffalo 136
Woodbridge 131
Nanchang 130
Altamura 122
Kraków 122
Ho Chi Minh City 101
Munich 100
Hebei 75
Kunming 72
Boardman 66
Pescara 66
São Paulo 64
Tianjin 62
Shenyang 52
Grevenbroich 50
Rome 45
Hong Kong 42
Hanoi 41
Milan 41
Redondo Beach 39
San Mateo 39
Jiaxing 36
Hefei 35
Houston 34
Augusta 33
Warsaw 33
Brno 31
Chennai 31
Stockholm 31
Ardabil 30
Changsha 30
Council Bluffs 30
London 30
Washington 30
Brooklyn 29
Montreal 29
Ancona 27
Leawood 27
Tokyo 27
Hangzhou 26
Helsinki 25
Norwalk 25
Brussels 24
Jinan 23
Kocaeli 23
Lanzhou 23
Mumbai 23
Rio de Janeiro 23
Seoul 23
Chicago 22
Toronto 22
Vasto 22
Denver 21
Moscow 21
Orange 21
Turku 21
Olomouc 20
Changchun 19
Amsterdam 18
Dong Ket 18
Teramo 18
Boston 17
Naples 17
San Francisco 17
Simi Valley 16
Atlanta 15
Orem 15
Shanghai 15
Torrevecchia Teatina 15
Johannesburg 14
Nuremberg 14
Phoenix 14
Seattle 14
Torino 14
Collecorvino 13
Auburn Hills 12
Bari 12
Belo Horizonte 12
Brasília 12
Totale 13.164
Nome #
Differenziamento reale e differenziamento temporaneo 238
Motivi di fosforilazione EPIYA nella patogenesi di Helicobacter pylori 212
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 211
Antimicrobial and Antibiofilm Efficacy of Graphene Oxide against Chronic Wound Microorganisms 183
Rilievo e ruolo del DNA extracellulare nel biofilm di Helicobacter pylori 169
Studio micriobiologico per il rilievo di Helicobacter pylory nel muco nasale di pazienti dispeptici 165
Effetto del 2-idrossietil-metacrilato (HEMA) sulla co-coltivazione di Streptococcus Mitis e fibroblastigengivali umani 162
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 162
Confronto di patterns di DNA da Helicobacter pylori isolati dal corpo e dall'antro 157
NUOVO TERRENO DI TRASPORTO “GESA” PER L’ISOLAMENTO DI HELICOBACTER PYLORI DA BIOPSIE GASTRICHE 155
Adhesion of human gingival fibroblasts/Streptococcus mitis co-culture on the nanocomposite system Chitlac-nAg 153
Biological Responses of Human Gingival Fibroblasts (HGFs) in an Innovative Co-Culture Model with Streptococcus mitis to Thermosets Coated with a Silver Polysaccharide Antimicrobial System. 150
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains 150
Isolamento di una proteina, mediante cromatografia di affinità con glutatione, da un ceppo anaerobio di Bacteroides fragilis. 146
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 141
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 141
Liposome-induced exfoliation of graphite to few-layer graphene dispersion with antibacterial activity 141
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 140
Antibacterial effect of plant extracts against Helicobacter pylori 140
Bacterial response to the exposure of 50 Hz electromagnetic fields. 139
Recupero di Helicobacter pylori ATCC 43504 dallo stato vitale non colturabile (VNC) 138
Arginine- and lysine-rich peptides: Synthesis, characterization and antimicrobial activity 135
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 134
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 134
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 133
The viable but not culturable (VBNC) state in helicobacter pylori 131
Transport medium for isolation and identification of Helicobacter pylori. 131
Carvacrol codrugs: A new approach in the antimicrobial plan 131
Effetto della deprivazione di 02 sulla morfologia e sulla crescita di Helicobacter pylori 130
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 129
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 128
New transport medium for cultural recovery of Helicobacter pylori 127
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 126
The effect of a silver nanoparticle polysaccharide system on streptococcal and saliva-derived biofilms. 126
Valutazione dell'adesività di ceppi del genere Proteus a cellule dell'epitelio urinario. 125
Bio-Toxicological Assay to Test Water and Sediment Quality. 125
Trasmissione di Helicobacter pylori in un modello murino 124
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 123
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 123
Activity of tea tree oil and nerolidol alone or in combination against Pediculus capitis (head lice) andits eggs 122
Cephalosporins are scavengers of hypochlorous acid 121
Attività in vitro di Tea Tree oil e Nerolidol da soli e in combinazione nei confronti di Pediculus capitis e delle sue lendini 121
Attività in vitro di farmaci antibatterici verso ceppi di Proteus spp. causanti U.T.I. 119
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 119
Preliminary studies on the effect of glutathione S-transferase from Providencia stuartii on the antimicrobial activity of different antibiotics. 118
Biofilm formation and modulation of luxS and rpoD expression by Helicobacter pylori. 118
Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus 118
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 118
A model of Helicobacter pylori persistence in a case of gastric cancer 116
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 116
Adhesive properties of Proteus genus related with antimicrobial agents resistance. 115
In vitro activity of Aloe vera inner gel against microorganisms grown in planktonic and sessile phases 114
Complex Electromagnetic Fields Reduce Candida albicans Planktonic Growth and Its Adhesion to Titanium Surfaces 114
Questionario di Microbiologia 113
Detection of Helicobacter pylori in saliva and esophagus 113
Helicobacter pylori in fase planctonica e sessile: comportamento in risposta a diversi terreni di coltura 113
Effetto del sistema polisaccaridico di nanoparticelle d’argento (Chitlac-nAg) sui biofilm di Streptococchi orali e saliva 112
Purification and characterization of three forms of glutathione transferase from Proteus mirabilis. 111
Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides 111
Biofilms in Chronic Wound Infections: Innovative Antimicrobial Approaches Using the In Vitro Lubbock Chronic Wound Biofilm Model. 110
The effect of O2 deprivation on the morphology and growth of Helicobacter pylori 110
Effect of Pefloxacin of Proteus-Providencia spp. to squamous epithelial cells. 110
Studio preliminare sull'inattivazione di farmaci antibiotici da parte di una trasferasi prodotta da Providencia stuartii. 110
In vitro activity of Aloe vera inner gel against microorganism grown in planktonic and sessile phase 110
Effects of Extremely Low-Frequency Electromagnetic Fields on Helicobacter pylori Biofilm. 110
Glutathione transferase in bacteria: subunit composition and antigenic characterization. 109
Extracellular DNA in Helicobacter pylori biofilm: a backstairs rumor 109
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 108
Selezione in vitro delle resistenze a beta-lattamine in recenti stipiti ospedalieri di Enterobacteriaceae e Pseudomonas. 108
Detection of Helicobacter pylori in esophagus and saliva in humans 108
Antimicrobial peptide l18r displays a modulating action against inter-kingdom biofilms in the lubbock chronic wound biofilm model 108
Prevalenza della glutatione transferasi nella regione periplasmatica di Proteus mirabilis 107
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 107
Transmission of Helicobacter pylori in an animal model. 107
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 107
Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? 106
Detection of Helicobacter pylori associated with zooplankton 106
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 106
Distribuzione degli isoenzimi della glutatione trasferasi in vari ceppi batterici. 105
Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode 105
Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. 104
Effetti del 2-idrossi-etil-metacrilato sul Biofilm prodotto da Streptococchi orali 104
Saliva improves Streptococcus mitis protective effect on human gingival fibroblasts in presence of 2-hydroxyethyl-methacrylate 103
Dynamic colonization of Helicobacter pylori in human gastric mucosa. 102
Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer 102
Necrosis and/or Apoptosis in Helicobacter pylori 102
Microbial Contamination of Smartphone Touchscreens of Italian University Students 102
Anti-adhesive and pro-apoptotic effects of 2-hydroxyethyl methacrylate on human gingival fibroblasts co-cultured with Streptococcus mitis strains. 102
Liposomes as effective exfoliating agents for graphite 101
Caratterizzazione e significato clinico della conversione morfologica di helicobacter pylori 100
Streptococcus mitis/human gingival fibroblasts co-culture: the best natural association in answer to the 2-hydroxyethyl methacrylate release. 100
Caratterizzazione di un isolato marino di Helicobacter pylori 100
Biofilm di Helicobacter pylori: un ambiente naturale per favorire la variabilità genetica 100
Studio in vitro sulla sensibilità di germi del gruppo Morganella-Proteus-Providencia verso aminoglicosidi, penicilline e cefalosporine. 99
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 98
Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. 98
Analisi della variabilità genetica, della sensibilità antimicrobica e dei fattori di virulenza in ceppi di Helicobacter pylori 98
Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms 98
Antimicrobial Combined Action of Graphene Oxide and Light Emitting Diodes for Chronic Wound Management 98
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 97
Totale 12.304
Categoria #
all - tutte 90.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021975 0 0 0 0 0 290 25 24 113 226 205 92
2021/20221.180 34 16 39 237 85 22 19 87 120 57 129 335
2022/20233.067 285 402 203 299 268 620 203 218 358 59 92 60
2023/20241.420 82 57 85 54 66 468 340 44 13 27 32 152
2024/20254.040 278 769 675 69 66 129 121 181 419 172 415 746
2025/20263.846 602 355 996 1.081 704 108 0 0 0 0 0 0
Totale 23.206